期刊文献+

下肢骨折术后血栓前状态的研讨 被引量:9

Studies and Discussion of of Prethrombotic State In patients with fracture of the lower limbs
下载PDF
导出
摘要 目的探讨血栓前状态与下肢骨折术后的关系及临床意义。方法对既往无血栓形成病史的下肢骨折住院病人(合并其它部位骨折者也纳入统计组)进行实验室指标监测,并将患者手术前后所测得的数据进行统计学描述及配对的差异性比较。结果下肢骨折患者术后相应的血栓前状态实验室指标(D-二聚体,纤维蛋白原,VWF)均显著升高,经T检验,患者手术前后所测得FB、D二聚体、VWF数据的配对差异性比较有统计学意义。结论骨科患者术后处于下肢深静脉栓塞的血栓前状态(PTS),建议给予预防性的抗凝治疗。 Objective To Study and Discuss the relation and clinical evidence between Prethrombotic State and patients with the lower limb fracture. Methods Firstly, inpatients who suffered the fracture of the lower limbs, and hadn't DVT history before (the patients with other fracture were accounted to experimental group),Then we monitored laboratorial data, done the statistics analysis of PT、APTT、FB、D-Dmier、VWF and etc between preoperative patients and postoperative patients, and done pairing difference contrast. Results The laboratorial data(FB、 D-Dmier.VWF)that obtain from inpatients who suffered the fracture of the lower limbs can prove the prethrombosis stage, showed positive results. They had significant difference on FB、D-Dmier、VWF between preoperative patients and postoperative patients by T-test. Conclusions postoperative patients are in Prethrombotic State, it is suggested that these patients will be done preventive anticoagulation treatment.
出处 《国际医药卫生导报》 2006年第8期10-12,共3页 International Medicine and Health Guidance News
关键词 下肢骨折 术后 血栓前状态 fracture of the lower limbs postoperative Prethrombotic State
  • 相关文献

参考文献16

  • 1邱贵兴,戴尅戎,杨庆铭,裴福兴,陈百成,曾炳芳,陈安民,王坤正,王继芳,余楠生,周乙雄,孙天胜,刘强,胡永成.预防骨科大手术后深静脉血栓形成的专家建议——深静脉血栓形成预防座谈会纪要[J].中华骨科杂志,2005,25(10):636-640. 被引量:477
  • 2Girard P,Musset D.Parent F,et al.High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism[J].Chest,1999,116:903-8
  • 3Lethen H,Flachskampf FA,Schneider R,et al.Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack[J].Am J Cardiol,1997,80:1066-9
  • 4Geerts WH,Heit JA,Clagett GP,et al.Prevention of venous thromboembolism.Sixth ACCP consensus conference on antithrombotic therapy[J].Chest,2001,119(Suppl):132S-175S
  • 5Gallus AS.Applying risk assessment models in orthopaedic surgery:overview of our clinical experience[J].Blood Coagul Gibrinolysis,1999,10:S53-61
  • 6Dahl OE,Andreassen G,Aspelin T,et al.Prolonged thrombo-prophylaxis following hip replacement surgery.Results of a double-blind,prospective,randomized placebo-controlled study with dalteparin (Fragmin)[J].Thromb Haemost,1997,77:26-31
  • 7Hull RD,Pineo GF,Francis SW,et al.Low-molecularweight heparin prophylaxis using dalteparin extended out-of-hospital warfarin versus out-of-hospital placebo in hip arthroplasty patients.A doubleblind,randomized comparison[J].Arch Intern Med,2000,160:2208-15
  • 8Seagroatt V,Tan HS,Goldacre M,Bulstrode C,Nugent I,Gill L.Elective total hip replacement:incidence,emergency readmission rate,and postoperative mortality[J].BMJ,1991,303:1431-5
  • 9Rugge ri Z M.Mechannisms initiating platelet thrombus for-mation[J].Thromb Hae most,1997,78:611
  • 10Palevsky HI,Kelley MA,Fish man AP.Pulmonary thromboe mbolic disease.In:Fishman AP(e d).Fishman's pul-monary diseases and disorders[M].New York:me Graw-Hill Co,1998:1297

二级参考文献42

  • 1Blake G J, Ridker P M. Novel clinical markers of vascular wall inflammation. Circ Res, 2001, 89: 763--771.
  • 2Libby P. Changing concepts of atherogenesis. J Internal Med, 2000, 247: 349--358.
  • 3Kabbani S S, Watkins M W, Holoch P A, et al. Platelet reactivity in coronary ostial blood: A reflection of the thrombotic state accompanying plaque rupture and of the adequacy of anti-thrombotic therapy. J Thromb Thrombolysis, 2001,12: 171--176.
  • 4Atalar E, Aytemir K, Haznedaroglu I, et al. Increased plasma levels of soluble selectins in patients with unstable angina. Int J Cardiol, 2001, 78:69--73.
  • 5Kayikcioglu M, Can L, Meto-Erdem N, et al. Soluble p-selectin and the success of thrombolysis in acute myocardial infarction. Int J Cardiol, 2001,79: 223--229.
  • 6Itoh T, Nakai K, Ono M, et al. Can the risk for acute cardiac events in acute coronary syndrome be indicated by platelet membrane activation marker p-selectin?Coron Artery Dis, 1995,6: 645--650.
  • 7Crea F, Biasucci L M, Buffon A, et al. Role of inflammation in the pathogenesis of unstable coronary artery disease. Am J Cardiol, 1997, 80(5A): 10E--16E.
  • 8Merten M, Thiagarajan P. P-selectin expression on platelet determines size and stability of platelet aggregates. Circulation, 2000,102: 1931--1936.
  • 9Yamazaki M, Uchiyama S, Iwata M. Measurement of platelet fibrinogen binding and P-selectin expression by flow cytometry in patients with cerebral infarction.Thromb Res, 2001, 104: 197--205.
  • 10Bienvenu J G, Tanguay J F, Theore J F, et al. Recombinant soluble P-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine. Circulation,2001, 103: 1128--1134.

共引文献695

同被引文献40

引证文献9

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部